[225Ac]Ac-AKY-1189 (therapeutic)
AKY-1189-01
Phase 1 small_molecule active
Quick answer
[225Ac]Ac-AKY-1189 (therapeutic) for Urothelial Carcinoma Bladder is a Phase 1 program (small_molecule) at Aktis Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aktis Oncology
- Indication
- Urothelial Carcinoma Bladder
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active